Document is current

Article History

Accepted: 26 May 2025

First Online: 29 June 2025

Change Date: 12 July 2025

Change Type: Update

Change Details: Figshare link updated.

Funding

: This podcast was funded by Pfizer.

: Brittany M. Szymaniak reports a consulting role for UroGPO. Alicia K. Morgans has received honoraria from AAA, Astellas Pharma, AstraZeneca, Bayer, Curium, Exelixis, Janssen, Lantheus, MacroGenics, Merck, Novartis, Pfizer, Sanofi, SMPA, and Telix. Neal D. Shore reports a consulting or advisory role for AbbVie, Akido, Alessa Therapeutics, Amgen, Arquer, Asieris, Astellas Pharma, AstraZeneca, Bayer, Boston Scientific, Bristol Myers Squibb, CG Oncology, Clarity Pharmaceuticals, Clovis Oncology, Dendreon, Exact Imaging, Exact Sciences, FerGene, Ferring, FIZE Medical, Foundation Medicine, Genentech, GenesisCare, Guardant Health, ImmunityBio, Incyte, Invitae, Janssen, Lantheus, Lilly, Mdxhealth, Merck, Minomic, Myovant Sciences, Myriad Genetics, Nymox, Pacific Edge Biotechnology, Pfizer, Photocure, PlatformQ, Profound, Promaxo, Propella Therapeutics, Protara, Sanofi, Sesen Bio, Specialty Networks, Telix Pharmaceuticals, Tolmar, UroGen Pharma, Vaxiion, and Vessi; providing expert testimony for Ferring; and leadership or other fiduciary role in another board, society, committee, or advocacy group with Photocure. Neal D. Shore is an Editorial Board member of Targeted Oncology. Neal D. Shore was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors contributed to the podcast design, outline development, and discussion.

: Medical writing support, under the direction of the authors, was provided by Ama Edusei, PharmD, of CMC Connect, a division of IPG Health Medical Communications funded by Pfizer, in accordance with Good Publication Practice (GPP 2022) guidelines. Pfizer’s generative artificial intelligence (AI)–assisted technology was used in the production of this publication to suggest content. After using this tool/service, the authors reviewed and edited the content as needed, and they take full responsibility for the content of the publication.